Skip to main content

Table 2 Risk factors for development of critical illness polyneuromyopathy

From: Is plasma calcium concentration implicated in the development of critical illness polyneuropathy and myopathy?

Variable Patients with CIPNM (n= 40) Patients without CIPNM (n= 150) P value
Age 68.7 ± 15.7 66.4 ± 15.9 0.55
Female gender 24 39 0.002
APACHE II score 23.7 ± 6.5 20.1 ± 7 0.04
SOFA score 8.4 ± 4.1 7.8 ± 4.2 0.16
Aminoglucosides 20 52 0.18
Corticosteroids 28 102 0.84
NMBA 16 40 0.35
Septic shock 33 93 0.04
Hyperglycemia 10 43 0.66
Hyperkalemia 0 1 1
Hypokalemia 5 14 0.49
Hypernatremia 6 9 0.14
Hyponatremia 7 30 0.89
Hypercalcemia 4 3 0.01
Hypocalcemia 37 114 0.02
  1. APACHE, Acute Physiology and Chronic Health Evaluation; CIPNM, critical illness polyneuromyopathy; NMBA, neuromuscular blocking agents; SOFA, Sequential Organ Failure Assessment.